Johnson & Johnson director granted 113 DSUs

Johnson & Johnson director Daniel E. Pinto received additional cash-settled deferred share units tied to JNJ’s stock value as part of his director fee deferral.

Rhea-AI Filing Summary

JOHNSON & JOHNSON (JNJ) director Daniel E. Pinto reported an acquisition of 113.098 Deferred Share Units (DSUs) on September 8, 2026 as a grant/award under the company's Amended and Restated Deferred Fee Plan for Directors. These DSUs are settled in cash upon termination of his directorship and each DSU reflects the fair market value of one share of common stock at settlement. After this award and related dividend equivalents, Pinto holds a total of 2,445.177 DSUs directly. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Grant/Award: 113.098 shares

Grant/Award 1 txn

Insider Pinto Daniel E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Share Units F1, F2	113.098	$276.31	$31K

Holdings After Transaction: Deferred Share Units — 2,445.177 contracts (Direct)

Footnotes (2)

1. F1. Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.
2. F2. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Key Figures

Deferred Share Units granted: 113.098 units Deferred Share Units after transaction: 2,445.177 units Underlying common stock per DSU: 1 share equivalent +2 more

5 metrics

Deferred Share Units granted 113.098 units Grant to director Daniel E. Pinto on September 8, 2026

Deferred Share Units after transaction 2,445.177 units Total DSUs held directly by Daniel E. Pinto after the grant

Underlying common stock per DSU 1 share equivalent Each DSU represents the fair market value of one share of common stock on the business day prior to settlement

Transaction type Grant, award, or other acquisition Code A derivative transaction for DSUs

Rule 10b5-1 plan status No Rule 10b5-1 plan reported Form-level checkbox is not affirmed

Key Terms

Deferred Share Units, dividend equivalent rights, Deferred Fee Plan for Directors

3 terms

Deferred Share Units financial

"Acquisition of Deferred Share Units (DSU) for deferral of cash retainer"

Deferred share units are promises that give an executive or director the right to receive company shares or their cash value at a future date, often when they retire or leave the company. Think of them as a paycheck held in a savings account that converts into stock later; they matter to investors because they tie pay to long-term performance, create potential future dilution of shares, and represent a delayed cash or share obligation the company must eventually fulfill.

dividend equivalent rights financial

"Includes dividend equivalent rights in connection with the Issuer's quarterly dividend"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

Deferred Fee Plan for Directors financial

"under the Issuer's Amended and Restated Deferred Fee Plan for Directors"

FAQ

What transaction did JNJ director Daniel E. Pinto report on this Form 4?

He reported a grant of 113.098 Deferred Share Units on September 8, 2026 as a compensation-related acquisition under Johnson & Johnson’s Amended and Restated Deferred Fee Plan for Directors, increasing his directly held DSUs.

How many Deferred Share Units does Daniel E. Pinto hold in JNJ after this transaction?

After the September 8, 2026 grant, Daniel E. Pinto holds a total of 2,445.177 Deferred Share Units directly, including amounts attributable to dividend equivalent rights accrued on previously held DSUs.

Are the JNJ Deferred Share Units held by Daniel E. Pinto settled in stock or cash?

The Deferred Share Units are settled in cash upon termination of Daniel E. Pinto’s directorship. Each DSU represents the fair market value of one share of Johnson & Johnson common stock on the business day prior to the settlement date.

What is the purpose of the Deferred Share Units granted to the JNJ director?

The DSUs were acquired for deferral of the director’s cash retainer under Johnson & Johnson’s Amended and Restated Deferred Fee Plan for Directors, effectively converting a portion of his director fees into cash-settled units linked to the company’s stock value.

Do the JNJ Deferred Share Units include dividend equivalents for Daniel E. Pinto?

Yes. The reported total of 2,445.177 DSUs includes dividend equivalent rights that accrue to Daniel E. Pinto in connection with Johnson & Johnson’s quarterly dividend on DSUs he holds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 08:52 PM Accepted by SEC EDGAR 09/10/2026 - 08:51 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pinto Daniel E

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NEW JERSEY 08933

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units	(1)	09/08/2026		A		113.098		(1)	(1)	Common Stock	113.098	$276.31	2,445.177(2)	D

Explanation of Responses:

1. Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

2. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Daniel E. Pinto	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)